Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.
Saved in:
| Title: | Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex. |
|---|---|
| Authors: | Feng Y; Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Grotegut S; Conrad Prebys Center for Chemical Genomics at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Jovanovic P; Lady Davis Institute, SMBD Jewish General Hospital, Gerald Bronfman Department of Oncology and Division of Experimental Medicine, McGill University, Montreal, QC, Canada., Gandin V; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, United States., Olson SH; Conrad Prebys Center for Chemical Genomics at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Murad R; Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Beall A; Immunology and Infectious Disease Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Colayco S; Immunology and Infectious Disease Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., De-Jesus P; Immunology and Infectious Disease Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Chanda S; Immunology and Infectious Disease Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., English BP; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, United States., Singer RH; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, United States., Jackson M; Conrad Prebys Center for Chemical Genomics at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States., Topisirovic I; Lady Davis Institute, SMBD Jewish General Hospital, Gerald Bronfman Department of Oncology and Division of Experimental Medicine, McGill University, Montreal, QC, Canada., Ronai ZA; Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Dec 19; Vol. 15, pp. 1528449. Date of Electronic Publication: 2024 Dec 19 (Print Publication: 2024). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1528449 |
